In addition to Mr. O’Neill, candidates whose names have recently surfaced include Dr. Scott Gottlieb, a former F. D. A. official with longstanding ties to pharmaceutical and biotech companies, and Dr. Joseph Gulfo, a former biotech and medical device executive. All three have called for streamlining the drug approval process, but Mr. O’Neill’s stance has drawn the most attention. He is a managing director of Mithril Capital Management, an investment firm Mr. Thiel   and previously led the Thiel Foundation, Mr. Thiel’s philanthropic organization. 